Abstract: The present invention relates to novel regulatory T cell proteins. One protein, designated PD-L3, resembles members of the PD-L1 family, and co-stimulates ?CD3 proliferation of T cells in vitro. A second, TNF-like, protein has also been identified as being upregulated upon ?CD3/?GITR stimulation. This protein has been designated Treg-sTNF. Proteins, antibodies, activated T cells and methods for using the same are disclosed.

Abstract: Systems and method automatically collect training data from manually created semantic relations, automatically extract rules from the training data to produce extracted rules, and automatically characterize existing semantic relations in the training data based on co-occurrence of the extracted rules in the existing semantic relations. Such systems and methods automatically construct semantic relation topics based on the characterization of the existing semantic relations, and group instances of the training data into the semantic relation topics to detect new semantic relations.

Abstract: The present invention relates to novel regulatory T cell proteins. One protein, designated PD-L3, resembles members of the PD-L1 family, and co-stimulates ?CD3 proliferation of T cells in vitro. A second, TNF-like, protein has also been identified as being upregulated upon ?CD3/?GITR stimulation. This protein has been designated Treg-sTNF.

Abstract: Systems and method automatically collect training data from manually created semantic relations, automatically extract rules from the training data to produce extracted rules, and automatically characterize existing semantic relations in the training data based on co-occurrence of the extracted rules in the existing semantic relations. Such systems and methods automatically construct semantic relation topics based on the characterization of the existing semantic relations, and group instances of the training data into the semantic relation topics to detect new semantic relations.

Abstract: The present invention relates to novel regulatory T cell proteins. One protein, designated PD-L3, resembles members of the PD-L1 family, and co-stimulates ?CD3 proliferation of T cells in vitro. A second, TNF-like, protein has also been identified as being upregulated upon ?CD3/?GITR stimulation. This protein has been designated Treg-sTNF. Proteins, antibodies, activated T cells and methods for using the same are disclosed.

Abstract: The present invention relates to novel regulatory T cell proteins. One protein, designated PD-L3, resembles members of the PD-L1 family, and co-stimulates ?CD3 proliferation of T cells in vitro. A second, TNF-like, protein has also been identified as being upregulated upon ?CD3/?GITR stimulation. This protein has been designated Treg-sTNF. Proteins, antibodies, activated T cells and methods for using the same are disclosed.

Abstract: The present invention relates to novel regulatory T cell proteins. One protein, designated PD-L3, resembles members of the PD-L1 family, and co-stimulates ?CD3 proliferation of T cells in vitro. A second, TNF-like, protein has also been identified as being upregulated upon ?CD3/?GITR stimulation. This protein has been designated Treg-sTNF.

Abstract: The present invention relates to novel regulatory T cell proteins. One protein, designated PD-L3, resembles members of the PD-L1 family, and co-stimulates ?CD3 proliferation of T cells in vitro. A second, TNF-like, protein has also been identified as being upregulated upon ?CD3/?GITR stimulation. This protein has been designated Treg-sTNF. Proteins, antibodies, activated T cells and methods for using the same are disclosed.

Abstract: The present invention relates to novel regulatory T cell proteins. One protein, designated PD-L3, resembles members of the PD-L1 family, and co-stimulates ?CD3 proliferation of T cells in vitro. A second, TNF-like, protein has also been identified as being upregulated upon ?CD3/?GITR stimulation. This protein has been designated Treg-sTNE Proteins, antibodies, activated T cells and methods for using the same are disclosed.

Abstract: A container for a battery includes a top portion having a generally rectangular shape and that is configured for coupling to a cover for the battery. The container also includes a plurality of cell containers extending from the top portion for housing wound cells elements. The cell containers have a generally cylindrical shape and are arranged in an offset configuration. The container also includes a structure extending from the top portion in an area of the top portion not supported by a cell container due to the offset cell container configuration. The structure provides enhanced structural rigidity for the top portion in the area of the top portion not supported by a cell container.